NEW YORK (GenomeWeb) - Sysmex today announced that it has partnered with Singapore-based Clearbridge BioMedics to jointly develop a new liquid biopsy system.

The partners will utilize Clearbridge's microfluidics-based rare cell separation technology, with the goal of potentially creating a new product line to complement Sysmex's current suite of hematology analyzers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.